Armistice Capital’s Statera Biopharma STAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
– Sell
-320,053
Closed -$1.1M – 143
2020
Q4
$1.1M Buy
+320,053
New +$911K 0.04% 98

Other funds holding STAB

Armistice Capital's STAB Position: Q1 2021 in Review

Armistice Capital sold out of Statera Biopharma (STAB) in Q1 2021, closing a stake of 320,053 shares — an estimated $1.1M sold.

Armistice Capital first reported a position in STAB in Q4 2020 and held it in 1 quarter. The position peaked at $1.1M in Q4 2020. 22 funds tracked by Wall St. Rank hold STAB as of Q1 2021.

  • Armistice Capital reported no remaining Statera Biopharma position as of Q1 2021 after selling out during the quarter.
  • Armistice Capital sold 320,053 Statera Biopharma shares in Q1 2021, an estimated $1.1M.
  • Armistice Capital first reported a position in Statera Biopharma in Q4 2020 and held it in 1 quarter.
  • Armistice Capital's Statera Biopharma position peaked at $1.1M in Q4 2020.
  • 22 funds tracked by Wall St. Rank held Statera Biopharma as of Q1 2021.

Based on Armistice Capital's 13F filing for Q1 2021, filed 17 May 2021.